A service of StreetInsider.com
Welcome

Most Popular

AAPL 140.02
C 26.20
GOOG 408.49
BAC 27.40
RIMM 69.71

Recently Added

SLAT 0.67
LNT 25.80
NDN 26.28
HTD 10.23
AGCO 29.88

Gaining Speed

SAPE 6.13
XYNH 0.01
ACCP 2.20
SNRY 0.57
CSG 45.46
28.70 -7.34 (-28.00%) GSK

Click Here to Receive Instant E-mail and RSS Alerts

Stock Details

Last Trade:28.70 Change:-7.34 (-28.00%) Prev Close:36.04 Open: 26.21 Days Range:25.00 – 29.98 52 Week Range: 27.15 - 49.48 Volume:445783 P/E: N/A
EPS:0.00

Member Comments

No member comments available for GSK


Not logged in - Log in or Sign up to leave comments

View AllRecent Alerts 07/03/09

Recent Alert on 07/01/09 at 7:25am
Piper Jaffray Downgrades Phase Forward (PFWD) to Neutral; Lack of Near-Term Catalysts

Piper Jaffray & Co. downgrades Phase Forward (Nasdaq: PFWD) from Buy to Neutral. Piper analyst says, "GlaxoSmithKline (NYSE: GSK) signed a multi-year renewal agreement for PhaseForward's InForm Electronic Data Capture System. GSK is PFWD's... Read More

Recent Alert on 06/30/09 at 1:43pm
Phase Forward (PFWD) Signs Multi-Yr, Multi-Million Dollar Contract with GlaxoSmithKline (GSK)
Recent Alert on 06/17/09 at 9:48am
Morning Movers 6/17: MERX, CYTR, SVNT, MIPI, TSTR Higher; ETFC, CTIC, AIB Lower
Recent Alert on 06/17/09 at 8:17am
Antigenics (AGEN) Announces GlaxoSmithKline (GSK) Launches Phase 3 Study of RTS,S, Which Contains Antigenics' QS-21
Recent Alert on 06/15/09 at 7:11am
Synta (SNTA) and GlaxoSmithKline End Collaboration

View AllRecent Press Releases

Press Release on 06/29/09 at 8:00am
Launch of Targeted Agents and Increased Use of Maintenance Therapy Will Drive the Non-Small-Cell Lung Cancer Drug Market to Nearly Triple to Almost $10 Billion in 2018

View AllRecent SEC Filings

SEC Filing on 07/02/09 at 6:29am
Form 6-K GLAXOSMITHKLINE PLC For: Jul 02
SEC Filing on 07/01/09 at 11:58am
Form 6-K GLAXOSMITHKLINE PLC For: Jul 01
SEC Filing on 07/01/09 at 11:54am
Form 6-K GLAXOSMITHKLINE PLC For: Jul 01

View AllRecent Blog Posts

Blog Posts on 07/02/09 at 8:56am
FDA Helps Investors Look Past Box Warnings
Blog Posts on 07/01/09 at 5:00pm
European Dividend Trends
Blog Posts on 07/01/09 at 10:30am
Opportunities in Options Markets, Summer 2009
Blog Posts on 07/01/09 at 5:16am
Can Spectrum Pharmaceuticals Benefit from FDA Action on Zevalin?
Blog Posts on 06/30/09 at 4:14pm
Tylenol Ban Will Hurt Several Drug Manufacturers' Bottom Lines